1. ViiV and Gilead top 2018 pharma reputation survey — Amazon’s healthcare ambitions — KCI Files for $100 Million IPO -- See more on our front page news
    Plus NEW Board just launched:
    Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Pristique not unique

Discussion in 'Wyeth' started by Anonymous, Jan 13, 2007 at 11:25 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest


    In today's overly litigious society, it's safer for them to write a drug approved by the FDA for the disorder rather than writing it off label, for starters.

    There are very few identical generics. Only if the original manufacturer makes them are they identical and as pure, effective and safe.

    Psychological reasons. Many people are about brands rather than copycats. If you are willing to pay extra, so be it. God bless America and the right to choose!!!
     
  2. Anonymous

    Anonymous Guest

    I will sell pristique the best I can. I am still learning about it and am not really impressed with it. Maybe I will see a study that will change my mind. It looks like its side effect profile is pretty lengthy. I hope I misread because I really want it to do well for all of us that were retained.
     
  3. Anonymous

    Anonymous Guest

    As someone who is close to the Medical Affair, I hate to burst your bubble. Pristiq is not a good drug by any standard. We tried to get 100mg approved as the standard dose. But our patients got so sick that they could care less about the efficacy. They just couldn't tolerate the drug long enough to see any improvement. We were then forced to compromise the efficacy and tested the 50mg and hoped for the best. As far as we know, 50mg is about as effective as 100mg XR with no additional safety or novel features. So if you want to convert your current XR patients to Pristiq, you may not want those who are on 150mg XR and higher or your customers will be very disappointed. As an extension, we consider it as a failure. Our company may not want us know about this or to think this way as we can expect. We can only rely on marketing now for any hope as there is nothing else we can do on this end. Pharmacologically, we are very disappointed and it is certainly an inferior product.
     
  4. Anonymous

    Anonymous Guest

    All the Hitachis in the world can't give her an Effexor orgasm'.
     
  5. Anonymous

    Anonymous Guest


    I would believe you if I didn't know any better. The drug is very well tolerated and it is very effective. Just wait and see. They said the same shit about Lexapro.

    Shit, if an absolute piece of shit dirty dirty dirty high side effect drug that took 10 years to get approved, CYMBALTA, is making a billion$$$, just watch how Pristiq kicks ass.

    Tell the docs to try it and judge for themselves. We all know the studies are practically useless in the docs' eyes. People, just have faith on this one.
     
  6. Anonymous

    Anonymous Guest

    You'd better hope that Pristiq does a billion or there will be another round of layoffs mid-year I'd say in order to get to the 10% total company cut figure that was announced. I do NOT believe Pristiq will do well. Too much competition now and too much similarity to Effexor. Psych patients are on multiple drugs and will look to save a buck with generic effex. Sorry, this pigs ready for the barbeque.
     
  7. Anonymous

    Anonymous Guest

    You will owe me a BBQ dinner. I'm no "kool aid" drinker either. Bring beer too. It'll wash down those words you're gonna be eating. I'll supply you the Pristiq samples for your new found depression.

    The reason is that the prelim reports are that it's doing very very well in early patients.

    ummm....wasn't Lexapro too similar to Celexa? You are not in sales, my boy. Just leave it up to us pros. Your paycheck has always relied on us and we rarely ever let you down, and you know it. Just sit back and relax.
     
  8. Anonymous

    Anonymous Guest

    Plus, you don't have the big bucks that we're going to spend greasing the pockets of all the local psych docs. They respond to payouts with scripts. Those who write, get more and more bucks. It's simple really. The docs don't care if works, they only care how much Wyeth pays them to write.
     
  9. Anonymous

    Anonymous Guest

    Those patients doing so well are with doctors bought and paid for by Wyeth, who are you kidding. Do you really expect them to be honest and be cut out of being a speaker.
     
  10. Anonymous

    Anonymous Guest

    Read all about the Pristiq hot flash study done in Oregon on PubMed. HUGE dropout rate rendering any results meaningless. The product is one more cruel joke on women. Wyeth hates women and sees them only as exploitable cash cows. Really awful.

    Stress reduction is key in controlling hot flashes. Drugging women into chemical hazes as a substitute for life and attitude changes is reprehensible. Deep breathing controls hot flashes just as much as any harmful, side effect riddled drug.

    Women - don't let Wyeth do this to you .......... again!
     
  11. Anonymous

    Anonymous Guest

    Oh FUCK!!! The Premarin Troll is back!!!! This cunt will never die. Take some cyannide please!!!!!
     
  12. Anonymous

    Anonymous Guest

    You are obviously not a Wyeth Pharma person, or Wyeth employee, at all. You're busted. You can say a lot of bad things about how upper management treated the sales force during this RIF, but one thing that's NOT true in the slightest is that Wyeth "pays" doctors. As a matter of fact, Wyeth is without a doubt the most conservative big pharma company when it comes to entertainment or anything like that. They just don't do it. Period.

    Now I hate to be profane, but....go fuck yourself you slandering piece of pharma and Wyeth hating troll. Go back to your miserable 30 grand a year life, Ms or Mr. "Hoping to hit it big with a lawsuit"
     
  13. Anonymous

    Anonymous Guest

    The reason Lexapro is doing and has been doing so well is it's tolerability profile.

    The most important thing when developing an antidepressant is tolerability first, efficacy second, then safety. Lexapro is a week SSRI. but what about the 35% remission rates you get with a placebo? It goes to show you that the patients want to be told "This pill will make you feel better and you should not have the high rates of nausea, or discontinuation syndrome you would probably have with second line agents."

    The reason why Cymbalta has been doing well, is because of their marketing for DNP. Docs are writing that stuff in combo with Lyrica. Or they are just treating folks with it that come in complaining of unexplained vague aches and pain (somatic stuff).

    Pristiq better have a niche, or be better tolerated than XR. If we don't get the vaso indication, then the company better reduce its expecations on this product.
     
  14. Anonymous

    Anonymous Guest

    I read an article regarding Pristiq in which it was explained that the "des" means a subtraction of part of the original venlafaxine molecule. In fact, the new formulation will be better tolerated as the liver won't have to metabolize as much molecule as with EXR. Better tolerability is really the bottom line with Pristiq and I think we will have that as part of our detail pieces (I hope).
     
  15. Anonymous

    Anonymous Guest

    We will just have to wait and see- Lunesta is a great sleep aid- but insurance won't cover it due to generic Ambien-Pts are not going to pay 150.00 out of their pocket for this product. Their market share stinks. Most of the time generic Ambien works. No matter how much marketing P did- Exubera failed in the market place. I do think that if Wyeth doesn't advertise on TV- they will be hurt. After the Vytorin mess, many doctors are sticking with what they know and what is generic. They are very skeptical of what a rep tells them. Avandia is also a good example.
    Pristiq can be huge or fizzle- we will have to wait to see insurance coverage and how patients react to it- will it be different than how they respond to what is out there now. Let's be honest- we are reps, not pharmacologists, we only know what the company wants us to know. I have been burned too many times by my company not telling the whole story to believe everything a company tells me.
     
  16. Anonymous

    Anonymous Guest

    PP I think you are correct--we will have to wait and see where we are on the MC plans...tier 2 we will be golden but if tier 3 it will be a "fizzle"...pts are too cost sensitive in this economy.
     
  17. Anonymous

    Anonymous Guest

    With Pristiq we are reaching for straws. W/out vasomotor indication this drug will wimper to market - not roar!
     
  18. Anonymous

    Anonymous Guest

    Cost??? MC will probably be tier 3 or Blocked. then?
     
  19. Anonymous

    Anonymous Guest


    What's "MC"?
     
  20. Anonymous

    Anonymous Guest

    I think even with the vasomotor indication Pristiq might not take off. Women are taking control of their own bodies and I don't know if may women want the side effects of an antidepressant along with menapause.
    I read once that if you don't think something is a disease state- just wait- the Pharmaceutical industry will turn it into a disease state and have a medication for it-